SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-20-000064
Filing Date
2020-05-07
Accepted
2020-05-07 16:11:57
Documents
19
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-202005078xkdoc.htm 8-K 31693
2 PRESS RELEASE pdli-202005078xkex991.htm EX-99.1 232269
3 PRESENTATION pdli-202005078xkex992.htm EX-99.2 7234
4 pdllogoa33.jpg GRAPHIC 123123
5 slide1b22.jpg GRAPHIC 49912
6 slide2b21.jpg GRAPHIC 227111
7 slide3b21.jpg GRAPHIC 178458
8 slide4b21.jpg GRAPHIC 86096
9 slide5b21.jpg GRAPHIC 150197
10 slide6b21.jpg GRAPHIC 129769
11 slide7b21.jpg GRAPHIC 139493
12 slide8b19.jpg GRAPHIC 125308
13 slide9b18.jpg GRAPHIC 176526
14 slidy25.jpg GRAPHIC 87700
15 slidy26.jpg GRAPHIC 106971
16 slidy27.jpg GRAPHIC 149643
17 slidy28.jpg GRAPHIC 120339
18 slidy29.jpg GRAPHIC 109162
19 slidy30.jpg GRAPHIC 30982
  Complete submission text file 0000882104-20-000064.txt   3015539
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 20856481
SIC: 2836 Biological Products, (No Diagnostic Substances)